Tower Research Capital (TRC)’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.5K | Buy |
4,992
+2,149
| +76% | +$9.69K | ﹤0.01% | 3611 |
|
|
2025
Q1 | $13.2K | Sell |
2,843
-2,600
| -48% | -$12.1K | ﹤0.01% | 3392 |
|
|
2024
Q4 | $37.8K | Buy |
5,443
+3,584
| +193% | +$24.9K | ﹤0.01% | 2737 |
|
|
2024
Q3 | $9.85K | Sell |
1,859
-11,593
| -86% | -$61.4K | ﹤0.01% | 3826 |
|
|
2024
Q2 | $50.3K | Buy |
13,452
+12,930
| +2,477% | +$48.4K | ﹤0.01% | 3097 |
|
|
2024
Q1 | $3.68K | Sell |
522
-7,274
| -93% | -$51.3K | ﹤0.01% | 4819 |
|
|
2023
Q4 | $44K | Sell |
7,796
-9,367
| -55% | -$52.9K | ﹤0.01% | 3216 |
|
|
2023
Q3 | $82.2K | Buy |
17,163
+15,495
| +929% | +$74.2K | ﹤0.01% | 2128 |
|
|
2023
Q2 | $11.4K | Sell |
1,668
-676
| -29% | -$4.63K | ﹤0.01% | 3954 |
|
|
2023
Q1 | $18K | Buy |
2,344
+888
| +61% | +$6.82K | ﹤0.01% | 3557 |
|
|
2022
Q4 | $11K | Sell |
1,456
-13,364
| -90% | -$101K | ﹤0.01% | 3818 |
|
|
2022
Q3 | $121K | Buy |
14,820
+7,575
| +105% | +$61.8K | ﹤0.01% | 2402 |
|
|
2022
Q2 | $70K | Buy |
7,245
+4,630
| +177% | +$44.7K | ﹤0.01% | 2580 |
|
|
2022
Q1 | $37K | Buy |
2,615
+2,157
| +471% | +$30.5K | ﹤0.01% | 2962 |
|
|
2021
Q4 | $9K | Sell |
458
-927
| -67% | -$18.2K | ﹤0.01% | 4692 |
|
|
2021
Q3 | $31K | Buy |
1,385
+985
| +246% | +$22K | ﹤0.01% | 3349 |
|
|
2021
Q2 | $9K | Buy |
+400
| New | +$9K | ﹤0.01% | 4434 |
|